American Renal Associates Holdings IPO Research Information

American Renal Associates Holdings IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on American Renal Associates Holdings, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
American Renal Associates Holdings	ARA - NYSE	$20.00-$23.00	$22.00	$26.50	7.5 million	4/21/2016
Underwriter(s): BofA Merrill Lynch, Barclays, Goldman Sachs & Co., Wells Fargo Securities, SunTrust Robinson Humphrey
Co-Manager(s): Leerink Partners
Industry: Health Care
Filing(s): Filed 2015-08-31 Terms Added 2016-04-08

American Renal Associates Holdings Quote & Chart - Click for current quote - ARA

About American Renal Associates Holdings (adapted from American Renal Associates Holdings prospectus):
They are the largest dialysis services provider in the United States focused exclusively on joint venture partnerships with physicians.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ARA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.